Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
199 participants
OBSERVATIONAL
2008-10-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• participating hospitals (with audit) document all consecutive patients diagnosed with a disease of the distal thoracal aorta that receive one of the following therapies:
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Leipzig TAVI Registry
NCT05015452
Evaluation of the GORE® C3 Delivery System Module
NCT01398332
Over and Under/Aneugraft Pericardium Covered Stent Long Term Follow up Registry
NCT01307553
Observational Registry Characterizing the CTAG Device With ACTIVE CONTROL
NCT03286400
Post-market Registry of the AMDS for the Treatment of Acute DeBakey Type I Dissection
NCT03894033
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Surgical operation of the distal thoracal aorta
* Documentation of the indications, the procedural results and the clinical short- and long-term results of the endovascular and chirurgical treatment in day to day hospital routine.
* Documentation of the operational risk (Euroscore)
* Documentation of the technical enforcement of the procedure as well as the result of the intervention
* Documentation of the hospital lethality and the non-fatal serious complications (Spinal Cord Ischemia, SCI, Stroke, TIA, high blood loss etc.)
* Documentation of medication at hospital discharge
* Documentation of long-term lethality and non-fatal serious complications (SCI, Stroke, TIA, major bleeding etc.) as well as hospitalization, re-intervention rates and medicinal drug therapy after 30 days, 1, 3 \& 5 years.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stiftung Institut fuer Herzinfarktforschung
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raimund Erbel, MD
Role: STUDY_CHAIR
Westdeutsches Herzzentrum Essen
Holger Eggebrecht, MD
Role: STUDY_CHAIR
Westdeutsches Herzzentrum Essen
Thomas Helmberger, MD
Role: STUDY_CHAIR
Klinikum Bogenhausen
Christoph Nienaber, MD
Role: STUDY_CHAIR
Universitätsklinikum Rostock
Hüseyin Ince, MD
Role: STUDY_CHAIR
Universitätsklinikum Rostock
Harald Mudra, MD
Role: STUDY_CHAIR
Klinikum Neuperlach
Ralf Zahn, MD
Role: STUDY_CHAIR
Klinikum Ludwigshafen
Jochen Senges, MD
Role: STUDY_CHAIR
Institut für Herzinfarktforschung Ludwigshafen an der Universität Heidelberg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herz-Zentrum Bad Krozingen
Bad Krozingen, , Germany
Kerckhoff-Klinik GmbH
Bad Nauheim, , Germany
Segeberger Kliniken GmbH
Bad Segeberg, , Germany
Westdeutsches Herzzentrum Essen, Uniklinikum
Essen, , Germany
Klinikum Ludwigshafen
Ludwigshafen, , Germany
Universitätsklinikum Magdeburg
Magdeburg, , Germany
Städt. Klinikum München GmbH
München, , Germany
Universitätsklinikum Rostock
Rostock, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Aortenstent
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.